A study of a GLP-1 medicine in people with lymphedema.
Recruiting now. Registry record last updated June 10, 2025.
- Who can join
- Adults 18+, have lymphedema, BMI 23+.
- What you take
- Check ClinicalTrials.gov for this trial's study groups and what each group receives.
- How long it lasts
- The full study runs about 2 years.
- What you get
- Costs vary by study. Ask the study team what this one covers, including the study medicine, visits and travel, before you sign the consent form.
What this study is for
Primary condition: Lymphedema.
Full scientific study title: Efficacy of GLP-1 Receptor Agonists in Treating Upper and Lower Extremity Lymphedema.
Who can join
Adults 18+, have lymphedema, BMI 23+. A site coordinator confirms whether you qualify during a free screening visit. The exact medical requirements are below.
Where this trial is enrolling
This trial has 2 sites across 1 state. Contact a site coordinator directly to start screening.
New Jersey2 sites
- River CenterRed Bank, New Jersey
- 260 Old Hook Rd Suite 304Westwood, New Jersey
Timeline
Started enrolling: April 9, 2025. Expected completion: April 9, 2027. Last updated on ClinicalTrials.gov: June 10, 2025.
Official source
Every Monday we check this trial against ClinicalTrials.gov, the federal registry for clinical research. Last checked September 4, 2026. Confirm the current status there before you contact a site:
Other GLP-1 clinical trials
Back to the full directory → or take the matching quiz if you want clinical trials filtered to your conditions and location.